Very few sectors have been able to avoid the sell-off in May. The strongest of the group has been the biotech stocks, which measured by the Dow Jones Biotechnology Index, is at an all-time high.

The combination of new drug approvals by the FDA and the speculation of more mergers have been the catalysts behind the recent outperformance. There is no reason to doubt that this action will end anytime soon. With that said, it is time to evaluate the biotech ETFs.

ETFs
The iShares NASDAQ Biotechnology Index ETF (Nasdaq:IBB) is a basket of 118 biotech stocks that has over $1.8 billion in total assets. In 2012 alone, the ETF is up 21% and is at a new all-time high. Interestingly, it has a beta of 0.76 versus the S&P 500, contrary to the belief that the biotech sector is extremely volatile. The top ten holdings make up 54% of that allocation and the top holdings are Regeneron Pharmaceuticals (Nasdaq:REGN) and Amgen (Nasdaq:AMGN). Both stocks are trading near their best levels in years. The expense ratio is 0.48%.

The smaller SPDR S&P Biotech ETF (ARCA:XBI) has $576 million in total assets and is composed of 48 individual stocks. The ETF is up 25% in 2012 and is trading at a fresh all-time high. The top ten holdings make up 37% of the portfolio and the top two holdings are Human Genome Sciences (Nasdaq:HGSI) and Amylin Pharmaceuticals (Nasdaq:AMLN). HGSI is a recent takeover target and AMLN is up three-fold in the last six months. The expense ratio is 0.35%.

SEE: Mergers And Acquisitions: Understanding Takeovers.

The PowerShares Dynamic Biotechnology & Genome Portfolio ETF (ARCA:PBE) is not trading at an all-time high and is only up 9% in 2012. The ETF has a total of $133 million in assets. The portfolio of 30 stocks takes a slightly different approach with its selection process, by using price and earnings momentum. The top ten holdings make up 50% of the allocation and the top two holdings are Biogen Idec (Nasdaq:BIIB) and Gilead Sciences (Nasdaq:GILD). BIIB is trading at an all-time high and GILD has been strong recently. The expense ratio is 0.65%.

Selection Process
When it comes to choosing a biotech ETF, it is one of the most difficult decisions that sector investors will have to make. Historically, the three ETFs mentioned do not trade in unison and from year-to-year, the returns can vary greatly. This is due to the composition of the ETF, as the top two holdings of each ETF varies.

The Bottom Line
Everything from top holdings to fees are important when choosing the best biotech ETF for a portfolio. My current selection process points to XBI as the best of the group for investors looking to delve into the sector. The 0.35% expense ratio is the lowest of the group and the top ten only making up 37% is another positive. It seems that the best biotech ETFs also tend to be the most diversified.

SEE: Diversification: Protecting Portfolios From Mass Destruction.

Because the ETF is already up 25% in 2012 and trading at an all-time high, the best strategy is to wait for a normal pullback of a few percentage points and buy into the weakness. If you cannot wait, buy half a position now and the other half during a pullback.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Matthew McCall did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Mutual Funds & ETFs

    ETF Analysis: iShares Cali AMT-Free Muni Bond

    Learn more about the iShares California AMT-Free Municipal Bond exchange-traded fund, a popular tax-advantaged ETF that dominates its category.
  2. Mutual Funds & ETFs

    ETF Analysis: SPDR S&P Emerging Markets Dividend

    Learn more about the SDPR S&P Emerging Markets Dividend Fund, a yield-focused exchange-traded fund tracking global emerging economies.
  3. Mutual Funds & ETFs

    ETF Analysis: First Trust Dow Jones Global Sel Div

    Find out about the First Trust Dow Jones Global Select Dividend Index Fund, and learn detailed information about characteristics and suitability of the fund.
  4. Mutual Funds & ETFs

    ETF Analysis: U.S 12 Month Natural Gas

    Learn about the United States 12 Month Natural Gas Fund, an exchange-traded fund that invests in 12-month futures contracts for natural gas.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares Floating Rate Bond

    Explore detailed analysis and information of the iShares Floating Rate Bond ETF, and learn how to use this ETF as a defense against rising interest rates.
  6. Mutual Funds & ETFs

    ETF Analysis: ProShares UltraPro Short S&P500

    Find out information about the ProShares UltraPro Short S&P 500 exchange-traded fund, and learn detailed analysis of its characteristics and suitability.
  7. Mutual Funds & ETFs

    ETF Analysis: SPDR Barclays Investment Grd Fl Rt

    Learn more about the SPDR Barclays Investment Grade Floating Rate Fund, which tracks an index of highly rated floating debt securities.
  8. Mutual Funds & ETFs

    ETF Analysis: ALPS Medical Breakthroughs

    Learn more about a unique and innovative exchange-traded fund (ETF) in the biotechnology industry: the ALPS Medical Breakthroughs Fund.
  9. Mutual Funds & ETFs

    ETF Analysis: iShares US Healthcare

    Learn about the iShares U.S. Healthcare exchange-traded fund, which invests in a wide range of health care providers, hospitals and home care facilities.
  10. Mutual Funds & ETFs

    Top 5 Japan Mutual Funds

    Discover five of the most popular and best-performing mutual funds offering investors direct exposure to equities of Japanese companies.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Exchange-Traded Fund (ETF)

    A security that tracks an index, a commodity or a basket of assets ...
  3. Exchange-Traded Mutual Funds (ETMF)

    Investopedia explains the definition of exchange-traded mutual ...
  4. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  5. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  6. Lion economies

    A nickname given to Africa's growing economies.
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. What does a high turnover ratio signify for an investment fund?

    If an investment fund has a high turnover ratio, it indicates it replaces most or all of its holdings over a one-year period. ... Read Full Answer >>
  5. Does index trading increase market vulnerability?

    The rise of index trading may increase the overall vulnerability of the stock market due to increased correlations between ... Read Full Answer >>
  6. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!